Saunders Scott J 4
4 · Nutex Health Inc. · Filed Apr 24, 2026
Research Summary
AI-generated summary of this filing
Nutex Health (NUTX) Director Scott J. Saunders Receives RSU Award
What Happened
Scott J. Saunders, a director of Nutex Health, was granted 823 restricted stock units (RSUs) on April 23, 2026. The grant is reported at $0.00 per unit (no cash paid at grant); the RSUs are derivative awards that represent a contingent right to receive one share of Nutex Health common stock upon vesting.
Key Details
- Transaction date: April 23, 2026; Form 4 filed April 24, 2026 (timely filing).
- Award: 823 RSUs granted; grant price reported as $0.00; total reported immediate value $0.
- Vesting: 100% vests on April 23, 2027 (per footnote). If Saunders leaves without cause during the vesting period, RSUs vest pro‑rata for actual service time.
- Shares owned after transaction: not specified in the filing.
- Filing type: Award/Grant (derivative); not a purchase or sale of shares.
Context
RSUs are a form of equity compensation that convert into actual shares upon vesting. This grant does not involve an immediate cash purchase or sale and does not by itself indicate a buy/sell signal. The award simply grants the right to receive common shares in the future subject to the stated vesting conditions.
Insider Transaction Report
- Award
Restricted Stock Units (RSUs)
[F1][F2]2026-04-23+823→ 1,426 totalExercise: $0.00From: 2027-04-23Exp: 2027-04-23→ Common Stock (823 underlying)
Footnotes (2)
- [F1]Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
- [F2]On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.